T he temporal course of type B aortic dissection (TBAD) can be divided into several phases: hyperacute (<24 h), acute (within 2 weeks), subacute (2 weeks up to 3 months), and chronic (>3 months) (1) (2) (3) . This distinction has become highly important, because it may help to identify the time interval during which these patients are at higher risk for complications and, for selected patients, the optimal moment for TEVAR (Thoracic Endovascular Aortic Repair). Identification of both the optimal cohort and most ideal time to perform TEVAR remains a matter of debate.
The VIRTUE trial suggested that ideal timing of TEVAR should be in the subacute phase, when the aorta still has aortic plasticity, which leads to similar remodeling and survival rates compared with treatment in the acute setting (3) . In addition, it may also be that the incidence of TEVAR-related complications, like retrograde dissection, is reduced by waiting a period of weeks after acute type B dissection.
In chronic TBAD, anatomic findings, such as narrow lumens and thickening of the intimal flap, may inhibit optimal aortic remodeling after TEVAR (4) .
Although open repair has higher operative mortality and morbidity, the previously noted anatomic issues are not insurmountable. However, no definitive evidence currently exists to confirm which method is optimal in uncomplicated type B dissection. In chronic TBAD, the indication for treatment is usually aneurysmal degeneration of the dissected segments of the aorta after initial medical therapy, which extends into the abdominal of the aorta in almost two-thirds of these patients (7-9).
After standard TEVAR, which includes stent graft treatment limited to the descending aorta, complete false lumen thrombosis during follow-up is described between 39% and 100% of patients (10), and rates of favorable aortic remodeling range between 5% and 89% (11) (12) (13) . In these patients, despite remodeling in the proximal stented sections, distal segments of the aorta may still be patent.
In the paper by Fanelli et al. (14) In addition to off-the-shelf devices, development of branched and fenestrated stent grafts specifically for chronic TBADs are needed, because continued perfusion of the distal aortic segments is often described, and stenting a longer section of the descending aorta may be necessary. This represents a problem with the current stent grafts, because they are not designed to also cover the visceral segments.
The entire field of TEVAR for aortic dissection is rapidly evolving. We need better technology, more randomized trials, and more precise phenotyping as we strive to optimize patient outcomes.
